Comprehensive Building Analytics

Global Pharmaceutical Research

Global Pharmaceutical saves $233,000 in annual energy costs while improving sustainability.

This Global Pharmaceutical company (GP)* is a leader in the discovery and the advancement in the treatment of some of the most difficult to treat diseases. GP employs more than 20,000 people globally, and its products are sold in more than 100 countries.

*Due to confidentiality agreements, we are not able to provide the client name. We will refer to the organization as GP throughout this case study.

The Challenge

GP has set long-term emissions reduction targets and expects to meet the goals through short term and longterm energy efficiency projects and operational improvements.

GP also expects to incorporate energy efficient design into new buildings and renovations, and to implement renewable energy projects. GP’s portfolio of buildings includes energy intensive research and development buildings, administrative offices, central plants, manufacturing, and distribution facilities across the globe.

GP’s goals include efficiency and sustainability through a 20% reduction of CO2 emissions by 2020. To this end, GP was interested in implementing targeted energy conservation measures and technologies at one of its campuses.

Results Achieved

  • Financial summary
  • Total energy savings: $233,000 (annual)
  • Simple payback: 0.4 years
  • Net present value: $561,000
  • Operational benefits
  • Sustainability and environmental stewardship:
    • Achieved 1,700+ metric tons in annual CO2 emissions reduction, which is the equivalent of taking 358 cars off the road.
  • Predictive maintenance: Initiated inspection and reprogramming of equipment prior to failure.
  • Vendor management: Verified optimum sequence of operations that were programmed into the building automation system (BAS) by outsourced facilities management vendors, and maintained 24/7 operations.